It’s about time.

This is a new and somewhat contentious vaccine that, in clinical trials, has been shown to be highly effective at conferring immunity against four members of the HPV family, HPV-16 and -18, responsible for the majority of cervical cancers, and HPV-6 and -11, which cause the majority of cases of genital warts. Today, the FDA approved Gardasil for use in female patients from 9-26, in order to better protect young women against cervical cancer.

Score: Sanity 1, Fundies 0.